Peptide detail

CJC-1295

CJC-1295 is a synthetic growth hormone releasing hormone (GHRH) analog designed to increase growth hormone secretion and IGF-1 levels. It comes in two variants: with and without Drug Affinity Complex (DAC). The DAC version has a significantly longer half-life (about 8 days versus minutes for the non-DAC version) due to its ability to bind to albumin in the bloodstream. CJC-1295 works by binding to GHRH receptors on the pituitary gland, stimulating the production and release of endogenous growth hormone. This leads to more natural GH pulses compared to exogenous GH administration. Benefits include increased muscle mass, reduced body fat, improved recovery, enhanced sleep quality, and potential anti-aging effects. It's frequently combined with GHRPs like Ipamorelin for synergistic effects on GH release.